Lincoln Pharmaceuticals Ltd reports Standalone Net Profit of Rs. 15.01 crore in Q1FY23
Mr. Mahendra Patel, MD, Lincoln Pharmaceuticals Ltd Business Highlights:- Total Income in Q1FY23 at Rs. 129.97 crore, up 24.4% from Rs. 104.4 crore in Q4FY22 Commercial operations of Cephalosporin Plant and Export to EU & Australia to commence in FY23 Read more